AbbVie , a research-based global biopharmaceutical company has announced that the U.S. Food and Drug Administration (FDA...
Glenmark Pharmaceuticals has announced that it has received approval from the Ministry of Healthcare, Russia to market M...
WHO welcomes the Government of Malawi’s launch of the world’s first malaria vaccine in a landmark pilot prog...
Recovery Force, LLC, a med tech innovation company, has received a $1.8 million grant from the National Institutes of He...
Eli Lilly and Company and Avidity Biosciences, Inc. have announced a global licensing and research collaborati...
PATH and Medicines for Malaria Venture (MMV) announce a 5-year, jointly-led initiative, VivAccess, to support count...
A foundational research roadmap for artificial intelligence (AI) in medical imaging was recently published in the journa...
Bio-Rad Laboratories, a global leader of life science research and clinical diagnostic products has announced the a...
Merck has announced that the U.S. Food and Drug Administration has approved KEYTRUDA, Merck’s anti-PD-1 therapy, i...
World Health Organization (WHO) has recently released new recommendations on 10 ways that countries can use digital heal...
Global pharma giant Boehringer Ingelheim (BI), which is present in both human and animal health, is particularly interes...
Research driven German Pharmaceutical giant Boehringer Ingelheim registered net sales of 17.5 billion Euros in 2018 and ...
Vonage, a global business cloud communications leader, has launched a new Enterprise Service Package and APIs via N...
Merck has launched a new and improved proprietary product: Arcofolin™ L-Methylfolate, a monosodium salt of L-...
Jackson ImmunoResearch, manufacturer of secondary antibodies for the life science market, announces a new range of produ...
Recently, the forum on medicines co-hosted by the World Health Organization (WHO) and the Government of South Africa, ai...
RayVio Corp., an advanced health and hygiene company, is shipping its new, 308 nm XR UVB LEDs and supporting the develop...
The Janssen Pharmaceutical Companies of Johnson & Johnson has announced that BALVERSA received accelerated...
